Open Access

Table 2

Crude and adjusted odds ratio and 95% confidence interval of acute pancreatitis associated with etodolac use.

Variable OR (95%CI) OR (95%CI)
Etodolac (never used as a reference)
Active use 5.00 (1.59, 15.8) 3.78 (1.11, 12.9)
Non-active use 1.95 (0.72, 5.27) 1.18 (0.38, 3.67)

Adjustment for other cyclooxygenase-2 inhibitors, alcohol-related disease, biliary stone, cardiovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, diabetes mellitus, hepatitis B, hepatitis C, and hypertriglyceridemia